Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Dynamics of genomic and immune responses during primary immunotherapy resistance in mismatch repair deficient tumors

ABSTRACT: Dynamics of genomic and immune responses during primary immunotherapy resistance in mismatch repair deficient tumors

PROVIDER: PRJNA671439 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer

Project description:This clinical trial evaluates the effect of tislelizumab in treating patients with mismatch repair deficient endometrial cancer that has come back (recurrent). Deoxyribonucleic acid (DNA) mismatch repair (MMR) is a system for recognizing and repairing DNA errors and damage. Mismatch repair deficient tumors (dMMR) may have difficulty repairing DNA mutations during replication that may affect tumor’s response to therapy. Immunotherapy with monoclonal antibodies, such as tislelizumab, may help the body’s immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving tislelizumab may help treat patients with mismatch repair deficient endometrial cancer.

| 2379033 | ecrin-mdr-crc

Dynamics of genomic and immune responses during primary immunotherapy resistance in mismatch repair deficient tumors

Project description:Dynamics of genomic and immune responses during primary immunotherapy resistance in mismatch repair deficient tumors

| PRJNA671440 | ENA

Novel Mechanisms of Antibiotic Resistance in Mismatch Repair-Deficient Pseudomonas aeruginosa hypermutators

Project description:Using in vitro directed evolution, we show that mismatch repair-deficient Pseudomonas aeruginosa can engage novel resistance mechanisms to ceftazidime-avibactam.

2021-08-30 | GSE180086 | GEO

Cisplatin-induced gene expression in DNA adenine methyltransferase (dam) and mismatch repair deficient E. coli

Project description:We used Affymetrix microarrays to determine the cisplatin-induced gene expression changes in E. coli deficient in dam and mismatch repair (dam, dam mutS, and mutS mutant strains). E. coli deficient in dam are hypersensitive to cisplatin. However introducing an additional mutation in mismatch repair (i.e., a mutation in mutS or mutL) abrogates this sensitivity and essentially restores wildtype levels of resistance. Keywords: Drug-induced expression

2005-07-27 | GSE2999 | GEO

Rhesus Macaque Model of Mismatch Repair-Deficient Colorectal Cancer

Project description:Rhesus Macaque Model of Mismatch Repair-Deficient Colorectal Cancer

| PRJNA738804 | ENA

Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal Cancer

Project description:This phase II trial studies how well danvatirsen and durvalumab work in treating patients with pancreatic cancer, non-small cell lung cancer and mismatch repair deficient colorectal cancer that has spread to other places in the body and does not respond to treatment. Danvatirsen may be used to block the production of proteins needed for tumor cell growth. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body’s immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving danvatirsen and durvalumab may work better at treating pancreatic cancer, non-small cell lung cancer and mismatch repair deficient colorectal cancer.

| 2231356 | ecrin-mdr-crc

Mismatch repair protein MLH1 suppresses replicative stress in BRCA2 deficient breast tumors

Project description:Mismatch repair protein MLH1 suppresses replicative stress in BRCA2 deficient breast tumors

| PRJNA912195 | ENA

GENOMIC INSTABILITY IN MISMATCH REPAIR DEFICIENT COLORECTAL CANCER

Project description:Here we performed whole exome sequencing on a series of 47 mismatch repair (MMR) deficient colorectal cancers (CRC) in order to identified key events in tumoral initiation and progression

| EGAS00001002477 | EGA

Transcription profiling of three human colorectal adenocarcinoma cells lines two which are mismatch repair deficient to characterize the post-transcriptional profile

Project description:characterize the post-transcriptional profile of mismatch repair-deficient colon cancer

2008-07-15 | E-MEXP-1696 | biostudies-arrayexpress

Gene Expression Profiling of Mismatch Repair Deficient Intestinal Stem Cells

Project description:Gene Expression Profiling of Mismatch Repair Deficient Intestinal Stem Cells

| PRJNA642180 | ENA